Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3301 C St
Sacramento, CA 95816Phone+1 916-734-6657Fax+1 916-451-7245
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 2007 - 2010
- Santa Clara Valley Medical CenterInternship, Transitional Year, 2006 - 2007
- Stanford University School of MedicineClass of 2006
Certifications & Licensure
- CA State Medical License 2017 - 2025
- MA State Medical License 2010 - 2018
- MO State Medical License 2007 - 2010
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- Epidermal spongiotic Langerhans cell collections, but not eosinophils, are a clue to the diagnosis of allergic contact dermatitis: A series of 170 clinically- and patc...Peggy A Wu, Jiejun Wu, Regina Liu, Sydney Sullivan, Olivia Keller
Journal of the American Academy of Dermatology. 2025-04-01 - To patch or not to patch on dupilumab: That is the question.Susan Nedorost, Peggy Wu, Jiade Yu, Jenny E Murase
Journal of the American Academy of Dermatology. 2025-04-01 - A Cross-Specialty Matched Comparison: Non-Dermatologists More Likely to Diagnose Dermatitis in Skin of Color Patients.Chidubem A V Okeke, Matthew Ponzini, Sydney D Sullivan, Lauren W Hastings, Olivia Keller
Dermatitis. 2025-02-19
Lectures
- Cochrane Skin Evidence Based Dermatology SymposiumAmerican Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019
Other
- Epidemiology and clinical features of basal cell carcinomaWu PA
http://www.uptodate.com/contents/epidemiology-and-clinical-features-of-basal-cell-carcinoma
UpToDate, Wolters Kluwer Health - 2013-01-17
Press Mentions
- CLL, GVHD May Raise Risk for Skin Cancer After Allo-HCTFebruary 28th, 2019
- CLL, GVHD May Raise Risk for Skin Cancer After Allo-HCTFebruary 28th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: